Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001140361-20-018160

Chief Financial Officer acquired 499,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

ALTMAN MICHAEL SETH · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-11 Other acquisition : show line 1 in the form +499,000 $10.00 $4,990,000 499,000 I
Loading xslF345X03/form4.xml…